The role of IL-6/JAK2/STAT3 signaling pathway in cancers

B Huang, X Lang, X Li - Frontiers in oncology, 2022 - frontiersin.org
Interleukin-6 (IL-6) is a pleiotropic cytokine involved in immune regulation. It can activate
janus kinase 2 (JAK2)-signal transducer and activator of transcription 3 (STAT3) signaling …

IL-6/JAK/STAT3 signaling in breast cancer metastasis: biology and treatment

SG Manore, DL Doheny, GL Wong, HW Lo - Frontiers in oncology, 2022 - frontiersin.org
Breast cancer is the most commonly diagnosed cancer in women. Metastasis is the primary
cause of mortality for breast cancer patients. Multiple mechanisms underlie breast cancer …

Mitochondrial fission links ECM mechanotransduction to metabolic redox homeostasis and metastatic chemotherapy resistance

P Romani, N Nirchio, M Arboit, V Barbieri, A Tosi… - Nature cell …, 2022 - nature.com
Metastatic breast cancer cells disseminate to organs with a soft microenvironment. Whether
and how the mechanical properties of the local tissue influence their response to treatment …

Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19

A Unterman, TS Sumida, N Nouri, X Yan… - Nature …, 2022 - nature.com
Dysregulated immune responses against the SARS-CoV-2 virus are instrumental in severe
COVID-19. However, the immune signatures associated with immunopathology are poorly …

S100A8 and S100A9 in Cancer

Y Chen, Y Ouyang, Z Li, X Wang, J Ma - Biochimica et Biophysica Acta …, 2023 - Elsevier
Abstract S100A8 and S100A9 are Ca 2+ binding proteins that belong to the S100 family.
Primarily expressed in neutrophils and monocytes, S100A8 and S100A9 play critical roles in …

Neutrophil calprotectin identifies severe pulmonary disease in COVID-19

H Shi, Y Zuo, S Yalavarthi, K Gockman… - Journal of Leucocyte …, 2021 - academic.oup.com
Severe cases of coronavirus disease 2019 (COVID-19) are regularly complicated by
respiratory failure. Although it has been suggested that elevated levels of blood neutrophils …

Perspective of mesenchymal transformation in glioblastoma

Y Kim, FS Varn, SH Park, BW Yoon, HR Park… - Acta neuropathologica …, 2021 - Springer
Despite aggressive multimodal treatment, glioblastoma (GBM), a grade IV primary brain
tumor, still portends a poor prognosis with a median overall survival of 12–16 months. The …

A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors

MJ Alvarez, PS Subramaniam, LH Tang, A Grunn… - Nature …, 2018 - nature.com
We introduce and validate a new precision oncology framework for the systematic
prioritization of drugs targeting mechanistic tumor dependencies in individual patients …

Function of HNRNPC in breast cancer cells by controlling the dsRNA‐induced interferon response

Y Wu, W Zhao, Y Liu, X Tan, X Li, Q Zou, Z Xiao… - The EMBO …, 2018 - embopress.org
Elevated expression of RNA binding protein HNRNPC has been reported in cancer cells,
while the essentialness and functions of HNRNPC in tumors were not clear. We showed that …

The recurrent architecture of tumour initiation, progression and drug sensitivity

A Califano, MJ Alvarez - Nature Reviews Cancer, 2017 - nature.com
Recent studies across multiple tumour types are starting to reveal a recurrent regulatory
architecture in which genomic alterations cluster upstream of functional master regulator …